EUVIMEDEUVIMED entdecken
Crossref

Baseline glutamate-glutamine complex levels modulate antidepressant response to rTMS in major depressive disorder: Insights from magnetic resonance spectroscopy

Andan Qian, Sirui Wang, Gai Kong, Guanfu Wu, Ziyu Meng, Anastasios A Daskalakis, Yingying Tang, Fang Liu

Journal of Affective Disorders · 2025-12 · 390 · 120023

DOI: 10.1016/j.jad.2025.120023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Affective Disorders, 2025-12. Verfasst von Andan Qian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Mental Health and drug discovery, Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Psychi…. Hauptthemen laut MEDLINE: Major Depressive Disorder, Transcranial Magnetic Stimulation, Glutamine, Glutamic Acid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Shanghai Municipal Education Commission, Shanghai Clinical Research Center for Mental Health, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for major depressive disorder (MDD), but its neurometabolic effects remain unknown. This study examined whether rTMS outcomes depend on baseline medial prefrontal cortex (mPFC) glutamate-glutamine complex (Glx) levels and aimed to identify clinically translatable imaging biomarkers. METHODS: Seventy-six MDD patients and 44 healthy controls (HC) were enrolled. 39 patients underwent 20-session rTMS treatments and were divided into high Glx (hGlx, N = 20) and low Glx (lGlx, N = 19) subgroups based on the median baseline Glx levels of all patients in the MDD group (N = 76). Metabolite concentrations (GABA, Glx, Glx/GABA) changes within the mPFC were quantified via magnetic resonance spectroscopy. Baseline subgroup differences and their associations with treatment outcomes investigated. Diffusion MRI metrics were extracted from the corpus callosum (CC) for correlation analysis, including fractional anisotropy, radial diffusivity (RD), mean diffusivity (MD), and axial diffusivity (AD). RESULTS: After rTMS treatment, both Glx subgroups regained significant Glx-GABA coupling, mirroring the HC pattern. In the hGlx subgroup, baseline mPFC Glx, GABA, and Glx/GABA predicted improvements in Montgomery-Åsberg Depression Rating Scale and Hamilton Depression Rating Scale factor scores. Notably, hGlx patients exhibited higher CC RD and MD values, with mPFC Glx levels correlating specifically with the splenium of CC MD and AD. CONCLUSION: Subgroup analyses demonstrated baseline mPFC excitatory neurotransmission modulates rTMS efficacy. Higher Glx concentrations may synergize with adjacent white matter integrity to restore excitatory-inhibitory balance, supporting higher mPFC Glx as a predictive biomarker for rTMS outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderTranscranial Magnetic StimulationGlutamineGlutamic AcidPrefrontal CortexHumansFemaleMaleAdultMagnetic Resonance SpectroscopyMiddle AgedTreatment Outcomegamma-Aminobutyric Acid

Stichwörter der Autor:innen

DepressionDiffusion magnetic resonance imagingGlutamate-glutamine complexMagnetic resonance spectroscopyTranscranial magnetic stimulations

Substanzen

GlutamineGlutamic Acidgamma-Aminobutyric Acid

Autor:innen und Institutionen

  • Institute of Mental Health and drug discovery, Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Psychiatry, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China; Dep…
  • Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China.
  • School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.
  • Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario M5T 1R8, Canada.
  • Neuroimaging Core, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200030, China; Institutes of Medical Science and Department of Pharmacology and Toxicology, Psychiatry, Physio…
  • Institute of Mental Health and drug discovery, Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), School of Psychiatry, Wenzhou Medical University, Wenzhou, Zhejiang 325000, China; Cam…

Förderung

  • Shanghai Municipal Education Commission
  • Shanghai Clinical Research Center for Mental Health
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Qian, A., Wang, S., Kong, G., Wu, G., Meng, Z., Daskalakis, A. A., Tang, Y., & Liu, F. (2025). Baseline glutamate-glutamine complex levels modulate antidepressant response to rTMS in major depressive disorder: Insights from magnetic resonance spectroscopy. Journal of Affective Disorders, 390, 120023. https://doi.org/10.1016/j.jad.2025.120023

Vancouver

Qian A, Wang S, Kong G, Wu G, Meng Z, Daskalakis AA, et al. Baseline glutamate-glutamine complex levels modulate antidepressant response to rTMS in major depressive disorder: Insights from magnetic resonance spectroscopy. Journal of Affective Disorders. 2025;390:120023. doi:10.1016/j.jad.2025.120023

BibTeX
@article{Qian2025,
  author = {Qian, Andan and Wang, Sirui and Kong, Gai and Wu, Guanfu and Meng, Ziyu and Daskalakis, Anastasios A and Tang, Yingying and Liu, Fang},
  title = {Baseline glutamate-glutamine complex levels modulate antidepressant response to rTMS in major depressive disorder: Insights from magnetic resonance spectroscopy},
  journal = {Journal of Affective Disorders},
  year = {2025},
  volume = {390},
  pages = {120023},
  doi = {10.1016/j.jad.2025.120023}
}
Kostenlos starten →